Back to Country Data Country Overview:
Country Overview:
Eswatini
Last Updated: 24 September 2024
Drug Registration Status
Approved
Not
Approved
Approved
Under
Review
Review
Data not
available
available
Gilead's Truvada (TDF/xTC*) Registration
Approved N/A
N/A
Generic versions of TDF/xTC* for prevention
Not Approved
ViiV's Apretude (CAB for PrEP) Registration
Approved 2022 †
2022 †
IPM's Dapivirine Vaginal Ring Registration
Approved 2022
2022
Oral F/TAF (Descovy) Registration
Data Not Available
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)
Additional Product Approvals Information for Eswatini
† This country uses an alternate pathway for regulatory approval for these products. This country relies on approval from the South African Health Products Regulatory Authority (SAHPRA) and pre-qualification from the World Health Organization (WHO) to authorize an Import License.
Research, Demonstration and Implementation
Oral PrEP
5 Completed Projects
Dapivirine Vaginal Ring
2 Planned/Ongoing Projects
Injectable PrEP
1 Planned/Ongoing Projects